Trial Outcomes & Findings for Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation (NCT NCT02864862)
NCT ID: NCT02864862
Last Updated: 2022-12-16
Results Overview
Change in ridge dimension is calculated as the value at 6 months minus the value at baseline. To take ridge dimension measurements, impressions were taken at baseline and 6 months, models were made from these impressions, the models were scanned, and then ridge dimension of scanned models was assessed using software. Ridge dimension was assessed at (and at 1mm increments below) the initial soft tissue margin.
COMPLETED
PHASE4
46 participants
baseline, 6 months after surgery
2022-12-16
Participant Flow
Participant milestones
| Measure |
Immediate Implant Combined With SCTG
Immediate implant plus Subepithelial connective tissue graft (SCTG)
|
Immediate Implant Combined With ADM
Immediate implant plus Acellular dermal matrix (ADM)
|
Immediate Implant
Immediate implant alone
|
|---|---|---|---|
|
Overall Study
STARTED
|
15
|
15
|
16
|
|
Overall Study
Received Intervention
|
15
|
15
|
16
|
|
Overall Study
3-month Follow up
|
15
|
15
|
16
|
|
Overall Study
6-month Follow up
|
15
|
15
|
15
|
|
Overall Study
12-month Follow up
|
14
|
15
|
14
|
|
Overall Study
COMPLETED
|
14
|
15
|
14
|
|
Overall Study
NOT COMPLETED
|
1
|
0
|
2
|
Reasons for withdrawal
| Measure |
Immediate Implant Combined With SCTG
Immediate implant plus Subepithelial connective tissue graft (SCTG)
|
Immediate Implant Combined With ADM
Immediate implant plus Acellular dermal matrix (ADM)
|
Immediate Implant
Immediate implant alone
|
|---|---|---|---|
|
Overall Study
Lost to Follow-up
|
1
|
0
|
1
|
|
Overall Study
Protocol Violation
|
0
|
0
|
1
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Immediate Implant Combined With SCTG
n=15 Participants
Immediate implant plus Subepithelial connective tissue graft (SCTG)
|
Immediate Implant Combined With ADM
n=15 Participants
Immediate implant plus Acellular dermal matrix (ADM)
|
Immediate Implant
n=16 Participants
Immediate implant alone
|
Total
n=46 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
61.53 years
STANDARD_DEVIATION 9.81 • n=15 Participants
|
63.53 years
STANDARD_DEVIATION 13.16 • n=15 Participants
|
58.88 years
STANDARD_DEVIATION 11.55 • n=16 Participants
|
61.26 years
STANDARD_DEVIATION 11.58 • n=46 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=15 Participants
|
8 Participants
n=15 Participants
|
9 Participants
n=16 Participants
|
24 Participants
n=46 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=15 Participants
|
7 Participants
n=15 Participants
|
7 Participants
n=16 Participants
|
22 Participants
n=46 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United States
|
15 Participants
n=15 Participants
|
15 Participants
n=15 Participants
|
16 Participants
n=16 Participants
|
46 Participants
n=46 Participants
|
|
Number of participants that smoke
|
1 Participants
n=15 Participants
|
0 Participants
n=15 Participants
|
4 Participants
n=16 Participants
|
5 Participants
n=46 Participants
|
|
Number of participants that have diabetes
|
6 Participants
n=15 Participants
|
2 Participants
n=15 Participants
|
0 Participants
n=16 Participants
|
8 Participants
n=46 Participants
|
|
Number of participants that have hypertension
|
3 Participants
n=15 Participants
|
5 Participants
n=15 Participants
|
5 Participants
n=16 Participants
|
13 Participants
n=46 Participants
|
|
Number of participants with anterior implant sites
|
7 Participants
n=15 Participants
|
6 Participants
n=15 Participants
|
9 Participants
n=16 Participants
|
22 Participants
n=46 Participants
|
|
Number of participants with pre molar implant sites
|
8 Participants
n=15 Participants
|
9 Participants
n=15 Participants
|
7 Participants
n=16 Participants
|
24 Participants
n=46 Participants
|
|
Implant diameter
3.5 millimeters (mm)
|
6 Participants
n=15 Participants
|
4 Participants
n=15 Participants
|
7 Participants
n=16 Participants
|
17 Participants
n=46 Participants
|
|
Implant diameter
4.3mm
|
8 Participants
n=15 Participants
|
11 Participants
n=15 Participants
|
9 Participants
n=16 Participants
|
28 Participants
n=46 Participants
|
|
Implant diameter
5.0mm
|
1 Participants
n=15 Participants
|
0 Participants
n=15 Participants
|
0 Participants
n=16 Participants
|
1 Participants
n=46 Participants
|
|
Implant length
10mm
|
0 Participants
n=15 Participants
|
3 Participants
n=15 Participants
|
0 Participants
n=16 Participants
|
3 Participants
n=46 Participants
|
|
Implant length
11.5mm
|
4 Participants
n=15 Participants
|
7 Participants
n=15 Participants
|
4 Participants
n=16 Participants
|
15 Participants
n=46 Participants
|
|
Implant length
13mm
|
8 Participants
n=15 Participants
|
5 Participants
n=15 Participants
|
8 Participants
n=16 Participants
|
21 Participants
n=46 Participants
|
|
Implant length
16mm
|
3 Participants
n=15 Participants
|
0 Participants
n=15 Participants
|
4 Participants
n=16 Participants
|
7 Participants
n=46 Participants
|
|
Mean probing depth(PD) of the tooth
|
2.28 millimeters
STANDARD_DEVIATION 0.47 • n=15 Participants
|
2.29 millimeters
STANDARD_DEVIATION 0.38 • n=15 Participants
|
2.24 millimeters
STANDARD_DEVIATION 0.45 • n=16 Participants
|
2.26 millimeters
STANDARD_DEVIATION 0.43 • n=46 Participants
|
|
Mean number of sites on tooth with bleeding on probing (BOP)
|
2.47 number of sites
STANDARD_DEVIATION 1.68 • n=15 Participants
|
2.60 number of sites
STANDARD_DEVIATION 1.72 • n=15 Participants
|
2.44 number of sites
STANDARD_DEVIATION 1.59 • n=16 Participants
|
2.50 number of sites
STANDARD_DEVIATION 1.66 • n=46 Participants
|
|
Mean number of sites on tooth with plaque (PL)
|
4.20 number of sites
STANDARD_DEVIATION 1.66 • n=15 Participants
|
4.13 number of sites
STANDARD_DEVIATION 2.13 • n=15 Participants
|
4.63 number of sites
STANDARD_DEVIATION 1.54 • n=16 Participants
|
4.32 number of sites
STANDARD_DEVIATION 1.78 • n=46 Participants
|
|
Width of keratinized tissue at baseline
|
4.70 millimeters
STANDARD_DEVIATION 1.16 • n=15 Participants
|
4.83 millimeters
STANDARD_DEVIATION 1.32 • n=15 Participants
|
4.50 millimeters
STANDARD_DEVIATION 1.20 • n=16 Participants
|
4.67 millimeters
STANDARD_DEVIATION 1.22 • n=46 Participants
|
|
Preoperative buccal soft tissue thickness
|
1.24 millimeters
STANDARD_DEVIATION 0.25 • n=15 Participants
|
1.34 millimeters
STANDARD_DEVIATION 0.25 • n=15 Participants
|
1.18 millimeters
STANDARD_DEVIATION 0.31 • n=16 Participants
|
1.25 millimeters
STANDARD_DEVIATION 0.27 • n=46 Participants
|
|
Postoperative buccal soft tissue thickness
|
2.38 millimeters
STANDARD_DEVIATION 0.32 • n=15 Participants
|
2.57 millimeters
STANDARD_DEVIATION 0.30 • n=15 Participants
|
1.18 millimeters
STANDARD_DEVIATION 0.31 • n=16 Participants
|
2.02 millimeters
STANDARD_DEVIATION 0.31 • n=46 Participants
|
|
Peri-implant marginal bone level
Mesial
|
-0.11 millimeters
STANDARD_DEVIATION 0.31 • n=15 Participants
|
-0.08 millimeters
STANDARD_DEVIATION 0.31 • n=15 Participants
|
-0.31 millimeters
STANDARD_DEVIATION 0.83 • n=16 Participants
|
-0.169 millimeters
STANDARD_DEVIATION 0.55 • n=46 Participants
|
|
Peri-implant marginal bone level
Distal
|
-0.03 millimeters
STANDARD_DEVIATION 0.10 • n=15 Participants
|
-0.95 millimeters
STANDARD_DEVIATION 2.30 • n=15 Participants
|
-0.36 millimeters
STANDARD_DEVIATION 1.21 • n=16 Participants
|
-0.44 millimeters
STANDARD_DEVIATION 1.49 • n=46 Participants
|
|
Peri-implant crestal bone level
Mesial
|
3.59 millimeters
STANDARD_DEVIATION 1.09 • n=15 Participants
|
3.01 millimeters
STANDARD_DEVIATION 1.08 • n=15 Participants
|
3.56 millimeters
STANDARD_DEVIATION 1.27 • n=16 Participants
|
3.39 millimeters
STANDARD_DEVIATION 1.15 • n=46 Participants
|
|
Peri-implant crestal bone level
Distal
|
3.02 millimeters
STANDARD_DEVIATION 1.21 • n=15 Participants
|
2.88 millimeters
STANDARD_DEVIATION 1.13 • n=15 Participants
|
3.31 millimeters
STANDARD_DEVIATION 1.19 • n=16 Participants
|
3.07 millimeters
STANDARD_DEVIATION 1.17 • n=46 Participants
|
PRIMARY outcome
Timeframe: baseline, 6 months after surgeryPopulation: Data were not collected for one participant in the immediate implant arm.
Change in ridge dimension is calculated as the value at 6 months minus the value at baseline. To take ridge dimension measurements, impressions were taken at baseline and 6 months, models were made from these impressions, the models were scanned, and then ridge dimension of scanned models was assessed using software. Ridge dimension was assessed at (and at 1mm increments below) the initial soft tissue margin.
Outcome measures
| Measure |
Immediate Implant Combined With SCTG
n=15 Participants
Immediate implant plus Subepithelial connective tissue graft (SCTG)
|
Immediate Implant Combined With ADM
n=15 Participants
Immediate implant plus Acellular dermal matrix (ADM)
|
Immediate Implant
n=15 Participants
Immediate implant alone
|
|---|---|---|---|
|
Change in Ridge Dimension
Initial soft tissue margin
|
-1.65 millimeters (mm)
Standard Deviation 1.27
|
-1.87 millimeters (mm)
Standard Deviation 1.19
|
-1.44 millimeters (mm)
Standard Deviation 0.98
|
|
Change in Ridge Dimension
2mm below initial soft tissue margin
|
-0.87 millimeters (mm)
Standard Deviation 0.71
|
-1.01 millimeters (mm)
Standard Deviation 0.66
|
-1.23 millimeters (mm)
Standard Deviation 0.61
|
|
Change in Ridge Dimension
3mm below initial soft tissue margin
|
-0.47 millimeters (mm)
Standard Deviation 0.62
|
-0.65 millimeters (mm)
Standard Deviation 0.66
|
-1.06 millimeters (mm)
Standard Deviation 0.66
|
|
Change in Ridge Dimension
5mm below initial soft tissue margin
|
0.14 millimeters (mm)
Standard Deviation 0.61
|
-0.17 millimeters (mm)
Standard Deviation 0.84
|
-0.64 millimeters (mm)
Standard Deviation 0.65
|
|
Change in Ridge Dimension
1mm below initial soft tissue margin
|
-1.37 millimeters (mm)
Standard Deviation 0.79
|
-1.60 millimeters (mm)
Standard Deviation 0.93
|
-1.41 millimeters (mm)
Standard Deviation 0.64
|
|
Change in Ridge Dimension
4mm below initial soft tissue margin
|
-0.15 millimeters (mm)
Standard Deviation 0.51
|
-0.37 millimeters (mm)
Standard Deviation 0.74
|
-0.86 millimeters (mm)
Standard Deviation 0.63
|
PRIMARY outcome
Timeframe: baseline, 12 months after surgeryPopulation: Data were not collected for 1 participant in the Immediate implant combined with SCTG arm and 2 participants in the Immediate implant arm.
Change in ridge dimension is calculated as the value at 12 months minus the value at baseline. To take ridge dimension measurements, impressions were taken at baseline and 12 months, models were made from these impressions, the models were scanned, and then ridge dimension of scanned models was assessed using software. Ridge dimension was assessed at (and at 1mm increments below) the initial soft tissue margin.
Outcome measures
| Measure |
Immediate Implant Combined With SCTG
n=14 Participants
Immediate implant plus Subepithelial connective tissue graft (SCTG)
|
Immediate Implant Combined With ADM
n=15 Participants
Immediate implant plus Acellular dermal matrix (ADM)
|
Immediate Implant
n=14 Participants
Immediate implant alone
|
|---|---|---|---|
|
Change in Ridge Dimension
3mm below initial soft tissue margin
|
-0.48 millimeters (mm)
Standard Deviation 0.63
|
-0.78 millimeters (mm)
Standard Deviation 0.65
|
-1.21 millimeters (mm)
Standard Deviation 0.82
|
|
Change in Ridge Dimension
4mm below initial soft tissue margin
|
-0.23 millimeters (mm)
Standard Deviation 0.60
|
-0.51 millimeters (mm)
Standard Deviation 0.55
|
-1.11 millimeters (mm)
Standard Deviation 0.85
|
|
Change in Ridge Dimension
Initial soft tissue margin
|
-1.80 millimeters (mm)
Standard Deviation 1.52
|
-2.33 millimeters (mm)
Standard Deviation 1.15
|
-1.91 millimeters (mm)
Standard Deviation 0.94
|
|
Change in Ridge Dimension
1mm below initial soft tissue margin
|
-1.21 millimeters (mm)
Standard Deviation 0.92
|
-1.61 millimeters (mm)
Standard Deviation 0.95
|
-1.54 millimeters (mm)
Standard Deviation 0.81
|
|
Change in Ridge Dimension
2mm below initial soft tissue margin
|
-0.87 millimeters (mm)
Standard Deviation 0.75
|
-1.08 millimeters (mm)
Standard Deviation 0.66
|
-1.27 millimeters (mm)
Standard Deviation 0.75
|
|
Change in Ridge Dimension
5mm below initial soft tissue margin
|
-0.02 millimeters (mm)
Standard Deviation 0.61
|
-0.41 millimeters (mm)
Standard Deviation 0.55
|
-0.90 millimeters (mm)
Standard Deviation 0.79
|
SECONDARY outcome
Timeframe: baseline, 6 months after surgeryPopulation: Data were not collected for one participant in the immediate implant arm.
Change in gingival level is calculated as the value at 6 months minus the value at baseline. Gingival level is measured at three sites: mesial, mid-buccal and distal sites. Gingival level is measured from a notch on a custom fabricated stent to the mucosal margin.
Outcome measures
| Measure |
Immediate Implant Combined With SCTG
n=15 Participants
Immediate implant plus Subepithelial connective tissue graft (SCTG)
|
Immediate Implant Combined With ADM
n=15 Participants
Immediate implant plus Acellular dermal matrix (ADM)
|
Immediate Implant
n=15 Participants
Immediate implant alone
|
|---|---|---|---|
|
Change in Gingival Level
Distal
|
-0.23 millimeters (mm)
Standard Deviation 0.62
|
-0.70 millimeters (mm)
Standard Deviation 0.92
|
-0.43 millimeters (mm)
Standard Deviation 0.94
|
|
Change in Gingival Level
Mesial
|
-0.47 millimeters (mm)
Standard Deviation 0.61
|
-0.9 millimeters (mm)
Standard Deviation 1.24
|
-0.67 millimeters (mm)
Standard Deviation 0.70
|
|
Change in Gingival Level
Mid-buccal
|
0.2 millimeters (mm)
Standard Deviation 0.90
|
-0.37 millimeters (mm)
Standard Deviation 1.03
|
0.3 millimeters (mm)
Standard Deviation 0.94
|
SECONDARY outcome
Timeframe: baseline, 6 months after surgeryPopulation: Data were not collected for one participant in the immediate implant arm.
Change in gingival thickness is calculated as the value at 6 months minus the value at baseline. Gingival thickness is measured using a stoppered endodontic file (#30) penetrating through the facial soft tissue 3 millimeters (mm) below the mid-buccal peri-implant mucosal margin.
Outcome measures
| Measure |
Immediate Implant Combined With SCTG
n=15 Participants
Immediate implant plus Subepithelial connective tissue graft (SCTG)
|
Immediate Implant Combined With ADM
n=15 Participants
Immediate implant plus Acellular dermal matrix (ADM)
|
Immediate Implant
n=15 Participants
Immediate implant alone
|
|---|---|---|---|
|
Change in Gingival Thickness
|
0.86 millimeters (mm)
Standard Deviation 0.25
|
0.97 millimeters (mm)
Standard Deviation 0.47
|
0.14 millimeters (mm)
Standard Deviation 0.14
|
SECONDARY outcome
Timeframe: baseline, 6 months after surgeryPopulation: Data were not collected for one participant in the immediate implant arm.
Change in width of keratinized gingiva is calculated as the value at 6 months minus the value at baseline.
Outcome measures
| Measure |
Immediate Implant Combined With SCTG
n=15 Participants
Immediate implant plus Subepithelial connective tissue graft (SCTG)
|
Immediate Implant Combined With ADM
n=15 Participants
Immediate implant plus Acellular dermal matrix (ADM)
|
Immediate Implant
n=15 Participants
Immediate implant alone
|
|---|---|---|---|
|
Change in Width of Keratinized Gingiva
|
0.27 millimeters (mm)
Standard Deviation 0.73
|
-0.47 millimeters (mm)
Standard Deviation 1.06
|
0.37 millimeters (mm)
Standard Deviation 0.85
|
SECONDARY outcome
Timeframe: baseline, 6 months after surgeryPopulation: Data were not collected for one participant in the immediate implant arm.
Change in alveolar bone level is calculated as the value at 6 months minus the value at baseline. The bone level measurement, taken from the standardized periapical radiographs, was defined as the distance from the first bone to implant contact (IB) at either the mesial or the distal aspect of the implant to the implant platform. Specifically, marginal bone level was defined as the distance between the vertical implant bone level (IB; the first bone to implant contact) and implant platform (IP). Crestal bone level was defined as the distance between the interproximal crestal bone level (IC) and implant platform (IP).
Outcome measures
| Measure |
Immediate Implant Combined With SCTG
n=15 Participants
Immediate implant plus Subepithelial connective tissue graft (SCTG)
|
Immediate Implant Combined With ADM
n=15 Participants
Immediate implant plus Acellular dermal matrix (ADM)
|
Immediate Implant
n=15 Participants
Immediate implant alone
|
|---|---|---|---|
|
Change in Alveolar Bone Level (Marginal)
Mesial
|
-0.45 millimeters (mm)
Standard Deviation 0.78
|
-0.70 millimeters (mm)
Standard Deviation 0.90
|
-0.37 millimeters (mm)
Standard Deviation 1.05
|
|
Change in Alveolar Bone Level (Marginal)
Distal
|
-0.19 millimeters (mm)
Standard Deviation 0.62
|
-0.27 millimeters (mm)
Standard Deviation 2.63
|
-0.40 millimeters (mm)
Standard Deviation 1.69
|
SECONDARY outcome
Timeframe: baseline, 6 months after surgeryPopulation: Data were not collected for one participant in the immediate implant arm.
Change in alveolar bone level is calculated as the value at 6 months minus the value at baseline. The bone level measurement, taken from the standardized periapical radiographs, was defined as the distance from the first bone to implant contact (IB) at either the mesial or the distal aspect of the implant to the implant platform. Specifically, crestal bone level was defined as the distance between the interproximal crestal bone level (IC) and implant platform (IP).
Outcome measures
| Measure |
Immediate Implant Combined With SCTG
n=15 Participants
Immediate implant plus Subepithelial connective tissue graft (SCTG)
|
Immediate Implant Combined With ADM
n=15 Participants
Immediate implant plus Acellular dermal matrix (ADM)
|
Immediate Implant
n=15 Participants
Immediate implant alone
|
|---|---|---|---|
|
Change in Alveolar Bone Level (Crestal)
Mesial
|
-0.62 millimeters (mm)
Standard Deviation 1.64
|
-0.35 millimeters (mm)
Standard Deviation 0.81
|
-0.43 millimeters (mm)
Standard Deviation 0.95
|
|
Change in Alveolar Bone Level (Crestal)
Distal
|
-0.88 millimeters (mm)
Standard Deviation 1.22
|
-0.74 millimeters (mm)
Standard Deviation 1.10
|
-0.78 millimeters (mm)
Standard Deviation 0.87
|
SECONDARY outcome
Timeframe: baseline, 6 months after surgeryPopulation: Data were not collected for one participant in the immediate implant arm.
Change in bone dimension is calculated as the value at 6 months minus the value at baseline. To measure bone dimensions, bone dimensions on cone beam computed tomography (CBCT) images were assessed using software. Bone dimension was assessed at the initial buccal crestal bone level (and at 1mm increments below).
Outcome measures
| Measure |
Immediate Implant Combined With SCTG
n=15 Participants
Immediate implant plus Subepithelial connective tissue graft (SCTG)
|
Immediate Implant Combined With ADM
n=15 Participants
Immediate implant plus Acellular dermal matrix (ADM)
|
Immediate Implant
n=15 Participants
Immediate implant alone
|
|---|---|---|---|
|
Change in Bone Dimension
Initial buccal crestal bone level
|
-1.34 millimeters (mm)
Standard Deviation 1.03
|
-0.85 millimeters (mm)
Standard Deviation 0.92
|
-0.77 millimeters (mm)
Standard Deviation 0.79
|
|
Change in Bone Dimension
2mm below initial crestal bone level
|
-1.40 millimeters (mm)
Standard Deviation 0.92
|
-0.93 millimeters (mm)
Standard Deviation 1.20
|
-1.10 millimeters (mm)
Standard Deviation 0.82
|
|
Change in Bone Dimension
4mm below initial crestal bone level
|
-0.76 millimeters (mm)
Standard Deviation 0.43
|
-0.71 millimeters (mm)
Standard Deviation 0.93
|
-0.48 millimeters (mm)
Standard Deviation 0.50
|
|
Change in Bone Dimension
5mm below initial crestal bone level
|
-0.62 millimeters (mm)
Standard Deviation 0.48
|
-0.66 millimeters (mm)
Standard Deviation 0.69
|
-0.46 millimeters (mm)
Standard Deviation 0.47
|
|
Change in Bone Dimension
7mm below initial crestal bone level
|
-0.44 millimeters (mm)
Standard Deviation 0.56
|
-0.59 millimeters (mm)
Standard Deviation 0.45
|
-0.56 millimeters (mm)
Standard Deviation 0.46
|
|
Change in Bone Dimension
8mm below initial crestal bone level
|
-0.52 millimeters (mm)
Standard Deviation 0.56
|
-0.50 millimeters (mm)
Standard Deviation 0.30
|
-0.58 millimeters (mm)
Standard Deviation 0.51
|
|
Change in Bone Dimension
9mm below initial crestal bone level
|
-0.46 millimeters (mm)
Standard Deviation 0.54
|
-0.28 millimeters (mm)
Standard Deviation 0.34
|
-0.47 millimeters (mm)
Standard Deviation 0.48
|
|
Change in Bone Dimension
Coronal third
|
-1.34 millimeters (mm)
Standard Deviation 0.65
|
-0.99 millimeters (mm)
Standard Deviation 0.98
|
-0.97 millimeters (mm)
Standard Deviation 0.63
|
|
Change in Bone Dimension
Middle third
|
-0.65 millimeters (mm)
Standard Deviation 0.43
|
-0.71 millimeters (mm)
Standard Deviation 0.69
|
-0.51 millimeters (mm)
Standard Deviation 0.48
|
|
Change in Bone Dimension
Apical third
|
-0.47 millimeters (mm)
Standard Deviation 0.53
|
-0.46 millimeters (mm)
Standard Deviation 0.32
|
-0.54 millimeters (mm)
Standard Deviation 0.45
|
|
Change in Bone Dimension
1mm below initial crestal bone level
|
-1.74 millimeters (mm)
Standard Deviation 0.94
|
-1.40 millimeters (mm)
Standard Deviation 1.39
|
-1.33 millimeters (mm)
Standard Deviation 1.11
|
|
Change in Bone Dimension
3mm below initial crestal bone level
|
-0.86 millimeters (mm)
Standard Deviation 0.47
|
-0.79 millimeters (mm)
Standard Deviation 1.10
|
-0.67 millimeters (mm)
Standard Deviation 0.56
|
|
Change in Bone Dimension
6mm below initial crestal bone level
|
-0.56 millimeters (mm)
Standard Deviation 0.52
|
-0.75 millimeters (mm)
Standard Deviation 0.57
|
-0.58 millimeters (mm)
Standard Deviation 0.51
|
Adverse Events
Immediate Implant Combined With SCTG
Immediate Implant Combined With ADM
Immediate Implant
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Chun-Teh Lee
The University of Texas Health Science Center at Houston
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place